VS

Vikas Saxena

Director Director DIN 05158573
DIN 05158573 First appointment Jan 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 3 historical roles
Total affiliations 3 Since Jan 2012
Shareholding value •••• Premium profile

About Vikas Saxena

Data last updated:

Vikas Saxena was a Director at Clival Private Limited (2018–2019), Director at Abha Biotechnology Private Limited (2018–2019) and Director at Shiv Nandi Investments Private Limited (2012–2015). The companies operate in Pharma, Agriculture and Travel and Hospitality.

DIN 05158573
Primary Designation Director
Industry Pharma
First Appointment 30 Jan 2012

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Clival Private Limited U74999UP2018PTC103182
Director13 Apr 20182018Active
Abha Biotechnology Private Limited U74999UP2018PTC102690
Director02 Apr 20182018₹80.7 Lakh (FY 2024)Active
Director30 Jan 20122012Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Clival Private Limited
Abha Biotechnology Private Limited
Shiv Nandi Investments Private Limited
Premium access

Shareholding and investment profile for Vikas Saxena

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vikas Saxena

Vikas Saxena was first appointed on 30 Jan 2012 as Director at Shiv Nandi Investments Private Limited. The most recent appointment on record is 13 Apr 2018 at Clival Private Limited.

Vikas Saxena held 3 earlier board appointments: Clival Private Limited (Director, 13 Apr 2018 to 21 Nov 2019); Abha Biotechnology Private Limited (Director, 02 Apr 2018 to 30 Mar 2019); Shiv Nandi Investments Private Limited (Director, 30 Jan 2012 to 07 Aug 2015).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available